A new targeted drug called HS-20093 shrank tumours in just over 1/2 of people in the ARTEMIS-001 trial with extensive-stage small cell #lungcancer.
Still early, but this is another sign that new treatment options may finally be starting to open up in SCLC. #LCSM
www.cell.com/cancer-cell/...
The rates of more than a dozen cancers are increasing among adults under the age of 50. What are the reasons behind it?
go.nature.com/4cKxhLN
🆕 real-world data from Brazil adds to the case for broad biomarker testing in non-squamous NSCLC.
NRG1 fusions found in 0.8% cases when DNA & RNA sequencing were used together. For rare but actionable alterations, how you test matters.
www.lungcancerjournal.info/article/S016... #LCSM #LungCancer
Severe COVID-19 may be associated with an increased subsequent risk of #lungcancer.
A 🆕 study published in Cancer Cell suggests that severe respiratory viral infections can leave lasting changes in the lung environment that may accelerate tumour growth.
🔗 www.cell.com/cell/abstrac... #LCSM
‼️ Lung Cancer Europe News is now live.
A 🆕 multilingual platform bringing together reliable updates on #lungcancer research, policy and advocacy across Europe.
Read news from across our network & from member organisations, & share member updates from your country. #LCSM
🌐 lungcancereuropenews.eu
Lung cancer is the biggest cancer killer of women in Europe yet is rarely recognised as a women’s health issue.
More women are being diagnosed across Europe, & in some countries deaths are still rising.
When we talk about women’s health, #lungcancer must be included.
#InternationalWomensDay #LCSM
Today at an online event hosted by the European Lung Foundation, Anna Keuchenius, AI & Community Insights Lead at Lung Cancer Europe, spoke about AI in #lungcancer care.
Her message: AI should support people not overwhelm them with disconnected apps and platforms.
#AIinHealth #LCSM
Michaela Regan Joins Lung Cancer Europe as EU Policy and Engagement Manager
@lungcancereurope.bsky.social
oncodaily.com/career/micha...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Michaela Regan joins us as our EU Policy & Engagement Manager.
With 8 yrs experience in public affairs patient engagement, inclu work in #lungcancer, she brings strong insight to our European policy work.
Michaela will help strengthen advocacy & support more equitable care across Europe. #LCSM
🔵🫁 #CATALUÑA | @aeacap.bsky.social organiza una nueva sesión de ‘Fent Camí’
➡️ Para propiciar encuentros lúdicos entre personas afectadas por el #cáncerdepulmón
🗓️ 6 de marzo
🕘 9.45h
📍 Subiremos a la montaña La Mola
👉🏼 Recorrido fácil y con poco desnivel
ℹ️ bit.ly/AEACaP-fent-...
Sharing from @go2forlungcancer.bsky.social
“We’ve got a community, we’ve got camaraderie and we’ve got support.” ✨ Survivor Spotlight: Dusty Donaldson
At the #VoicesSummit, she’s turning lived experience into legislative action, meeting with lawmakers to advocate for #LungCancer.
Have you led an initiative that improved patient care or supported carers?
Submit your proposal for the LCNUK Annual Award and highlight the impact of your work .
Applications close 24th April ▶️ ow.ly/m1bL50YcQ2A
Our March newsletter is out & for the first time, it’s multilingual.
We’ve also launched a new multilingual Lung Cancer Europe News website, with regular updates on #lungcancer policy, research & opportunities to get involved.
Read the newsletter 🔗 eepurl.com/jAC3HE #LCSM
Exploring the Impact of Artificial Intelligence in Cancer Care - Jame Abraham
@jameabraham.bsky.social
oncodaily.com/voices/jame-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Family history in #lungcancer is often misunderstood.
A 🆕 multicentre study in Lung Cancer found ~16% of people with NSCLC had enriched familial cancer patterns using a structured scoring system.
Not proof of inheritance but a signal for possible genetic counselling.
doi.org/10.1016/j.lu... #LCSM
Science Will Win podcast (live today) explains personalized medicine. I was their guest as example and expert at the same time 😀 link.podtrac.com/whifmgc8
🚨 Call for Proposals: European Health Forum #EHFG2026
Theme: "now is the time for stakeholders to champion health, solidarity and equity not as costs but as investments for a resilient future." www.ehfg.org/fileadmin/do...
🆕 Nature Cancer study shows layering fragment patterns on top of DNA methylation makes multicancer blood tests significantly more accurate.
#LungCancer survival depends heavily on stage at diagnosis. Earlier & more reliable detection could be transformative. #LCSM
www.nature.com/articles/s43...
#Lungcancer screening was on the agenda in Brussels at the European Cancer Screening Summit, organised by the @European Cancer Organisation.
The focus now is implementation. Turning pilots into national programmes.
🙏 for a really constructive event - ECO & the PRAISE-U, SOLACE & TOGAS teams. #LCSM
AI in research is moving fast. This piece in Nature looks at the rise of low-quality, AI-generated subs & the strain put on peer review systems.
In #lungcancer, AI has real potential. But credibility & quality are vital & speed can’t come at the expense of trust.
www.nature.com/articles/d41...
Plastic pollution is usually framed as an environmental issue. It may also be a lung health issue.
A new JCI viewpoint notes microplastics have been found in human lungs, & workers in plastic & rubber manufacturing face higher #lungcancer risk.
www.jci.org/articles/vie...
#LCSM
🇪🇺 EU countries scale back #tobacco #tax proposal: A win for industry #lobbying?
“When taxes are weaker, consumption stays higher, addiction lasts longer, and more people develop serious disease”
@lungcancereurope.bsky.social
www.theexamination.org/articles/eu-... @theexamination.org
Thanks for sharing, Paul.
Tobacco tax can sound technical, but the consequences are very human.
A randomised phase 3 trial in advanced non small cell #lungcancer found survival differed based on time of day treatment was given.
Same immunotherapy plus chemo. Just before vs after 3pm. Outcomes changed.
www.nature.com/articles/s41... #LCSM
‼️ Faecal transplant: 1st evidence showing it can improve response to immunotherapy in #lungcancer.
🆕 phase 2 trial data (Nature Medicine) show faecal microbiota transplantation given before anti-PD-1 immunotherapy linked to much higher response rates in NSCLC. #LCSM www.nature.com/articles/s41...
Registration Is Open for the 1st Lung Cancer Europe Conference
@lungcancereurope.bsky.social
oncodaily.com/voices/lung-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #LuCE #LungCancerEurope
🌱 Our 1st newsletter of ‘26 is out now.
It sets our priorities for the year & includes details about our 1st Annual Conference in Vienna (Apr 26). Designed for our members, this event will focus on practical exchange, collab, & strengthening #LungCancer advocacy in Europe.
eepurl.com/jvFAzQ #LCSM
Lung Cancer Europe - Exploring Immunotherapy Before Chemoradiotherapy in Unresectable Stage III Lung Cancer
@lungcancereurope.bsky.social
oncodaily.com/voices/lung-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #LungCancerEurope
Lung Cancer Europe - Confronting Nihilism and Stigma in Lung Cancer
@lungcancereurope.bsky.social
oncodaily.com/voices/nihil...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #LuCE
Lung Cancer Europe - Encouraging to See Lung Cancer Papers Across JCO’s Top Articles of 2025
@lungcancereurope.bsky.social
oncodaily.com/voices/top-a...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #LungCancerEurope
